These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8099697

  • 21. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A, Lipworth BJ.
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [Abstract] [Full Text] [Related]

  • 22. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI, Brittain RT, Coleman RA, Denyer LH, Jack D, Johnson M, Lunts LH, Nials AT, Sheldrick KE, Skidmore IF.
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
    Whelan CJ, Johnson M, Vardey CJ.
    Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
    [Abstract] [Full Text] [Related]

  • 24. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.
    Johnson M, Rennard S.
    Chest; 2001 Jul; 120(1):258-70. PubMed ID: 11451847
    [Abstract] [Full Text] [Related]

  • 25. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects.
    Guhan AR, Cooper S, Oborne J, Lewis S, Bennett J, Tattersfield AE.
    Thorax; 2000 Aug; 55(8):650-6. PubMed ID: 10899240
    [Abstract] [Full Text] [Related]

  • 26. [Inquiry into the mechanism of long-acting bronchodilators].
    Bao Y, Lemoine H.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):191-6. PubMed ID: 11367704
    [Abstract] [Full Text] [Related]

  • 27. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus.
    Naline E, Zhang Y, Qian Y, Mairon N, Anderson GP, Grandordy B, Advenier C.
    Eur Respir J; 1994 May; 7(5):914-20. PubMed ID: 7914176
    [Abstract] [Full Text] [Related]

  • 28. Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.
    van der Woude HJ, Aalbers R.
    Am J Respir Med; 2002 May; 1(1):55-74. PubMed ID: 14720076
    [Abstract] [Full Text] [Related]

  • 29. Why are long-acting beta-adrenoceptor agonists long-acting?
    Anderson GP, Lindén A, Rabe KF.
    Eur Respir J; 1994 Mar; 7(3):569-78. PubMed ID: 7912202
    [Abstract] [Full Text] [Related]

  • 30. Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro.
    Jeppsson AB, Källström BL, Waldeck B.
    Pharmacol Toxicol; 1992 Oct; 71(4):272-7. PubMed ID: 1360657
    [Abstract] [Full Text] [Related]

  • 31. Long-acting beta 2-agonists. Role in primary care asthma treatment.
    D'Urzo AD.
    Can Fam Physician; 1997 Oct; 43():1773-7. PubMed ID: 9356758
    [Abstract] [Full Text] [Related]

  • 32. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
    Holden NS, Rider CF, Bell MJ, Velayudhan J, King EM, Kaur M, Salmon M, Giembycz MA, Newton R.
    Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
    [Abstract] [Full Text] [Related]

  • 33. The pharmacology of salmeterol.
    Johnson M, Butchers PR, Coleman RA, Nials AT, Strong P, Sumner MJ, Vardey CJ, Whelan CJ.
    Life Sci; 1993 May; 52(26):2131-43. PubMed ID: 8099695
    [Abstract] [Full Text] [Related]

  • 34. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
    Bartow RA, Brogden RN.
    Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
    [Abstract] [Full Text] [Related]

  • 35. A comparison of the effect of salmeterol and salbutamol in normal subjects.
    Spring J, Clague J, Ind PW.
    Br J Clin Pharmacol; 1992 Feb; 33(2):139-41. PubMed ID: 1348000
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy.
    Buchwald A, Hochhaus G.
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):652-60. PubMed ID: 9877002
    [Abstract] [Full Text] [Related]

  • 37. Is there a need for another inhalative beta(2)-agonist besides formoterol in patients with asthma?
    Matthys H.
    Respiration; 2001 Dec; 68(4):432-7. PubMed ID: 11464097
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
    Nannini L, Lasserson TJ, Poole P.
    Cochrane Database Syst Rev; 2003 Dec; (4):CD003794. PubMed ID: 14583994
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.